EDGAR Filing Documents for 0001104659-15-017795

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001104659-15-017795

Filing Date

2015-03-06

Accepted

2015-03-06 17:23:45

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a15-6136_1s3.htm	S-3	624554
2	EX-1.2	a15-6136_1ex1d2.htm	EX-1.2	292787
3	EX-4.5	a15-6136_1ex4d5.htm	EX-4.5	548727
4	EX-4.7	a15-6136_1ex4d7.htm	EX-4.7	145873
5	EX-4.8	a15-6136_1ex4d8.htm	EX-4.8	147532
6	EX-4.9	a15-6136_1ex4d9.htm	EX-4.9	157864
7	EX-5.1	a15-6136_1ex5d1.htm	EX-5.1	33596
8	EX-12.1	a15-6136_1ex12d1.htm	EX-12.1	35274
9	EX-23.1	a15-6136_1ex23d1.htm	EX-23.1	4054
10	GRAPHIC	g61361bei001.jpg	GRAPHIC	6469
11	GRAPHIC	g61361cci001.jpg	GRAPHIC	6469
12	GRAPHIC	g61361cci002.jpg	GRAPHIC	6954
13	GRAPHIC	g61361bsi001.jpg	GRAPHIC	6469
14	GRAPHIC	g61361bsi002.jpg	GRAPHIC	6954
15	GRAPHIC	g61361lgi001.jpg	GRAPHIC	1980
	Complete submission text file	0001104659-15-017795.txt		2040848

Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677

Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300

EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)